Targeting the Effect of VEGF in Diabetic Macular Edema

Comment

Anthony P Adamis et al. N Engl J Med. 2015.

. 2015 Jul 30;373(5):480-1.

doi: 10.1056/NEJMc1505684.

Erratum in

Targeting the Effect of VEGF in Diabetic Macular Edema.
[No authors listed] [No authors listed] N Engl J Med. 2015 Sep 3;373(10):982. doi: 10.1056/NEJMx150032. N Engl J Med. 2015. PMID: 26332563 No abstract available.

No abstract available

Targeting the Effect of VEGF in Diabetic Macular Edema.
Wells JA 3rd, Glassman AR, Jampol LM. Wells JA 3rd, et al. N Engl J Med. 2015 Jul 30;373(5):481-2. doi: 10.1056/NEJMc1505684. N Engl J Med. 2015. PMID: 26222565 No abstract available.

Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.
Diabetic Retinopathy Clinical Research Network; Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW. Diabetic Retinopathy Clinical Research Network, et al. N Engl J Med. 2015 Mar 26;372(13):1193-203. doi: 10.1056/NEJMoa1414264. Epub 2015 Feb 18. N Engl J Med. 2015. PMID: 25692915 Free PMC article. Clinical Trial.